STAT, Managed Healthcare Executive and Others Cite Goodroot White Paper on Humira Biosimilars
A collaboration of multiple Goodroot community companies produced a comprehensive white paper on the arrival of biosimilars for Humira in the U.S. market and the potential impacts on pricing. Many media outlets throughout the healthcare industry have used our analysis to inform their coverage of this issue. Healthline based most of an article on an interview with …